Di Liu
- Biomedical Engineering top 5%
- Molecular Biology
- Materials Chemistry
- Nephrology top 2%
- Biomaterials top 5%
- Topics
- Nanoplatforms for cancer theranostics (10 papers)Renal Diseases and Glomerulopathies (9 papers)Acute Kidney Injury Research (8 papers)
- Partner nations
- ChinaUnited KingdomCzechia
In The Last Decade
Di Liu
45 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Biomedical Engineering 574
- Molecular Biology 507
- Materials Chemistry 339
- Nephrology 308
- Biomaterials 279
Countries citing papers authored by Di Liu
This map shows the geographic impact of Di Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Di Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Di Liu more than expected).
Fields of papers citing papers by Di Liu
This network shows the impact of papers produced by Di Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Di Liu. The network helps show where Di Liu may publish in the future.
Co-authorship network of co-authors of Di Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Di Liu. A scholar is included among the top collaborators of Di Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Di Liu. Di Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 101 | |
| 2 | 7 | |
| 3 | 3 | |
| 4 | 5 | |
| 5 | 11 | |
| 6 | 4 | |
| 7 | 19 | |
| 8 | 6 | |
| 9 | 9 | |
| 10 | 16 | |
| 11 | 11 | |
| 12 | 122 | |
| 13 | 161 | |
| 14 | ROS-responsive nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin for acute kidney injurybreakdown → | 266 |
| 15 | 26 | |
| 16 | 43 | |
| 17 | 30 | |
| 18 | 11 | |
| 19 | 9 | |
| 20 | 8 |
About Di Liu
Di Liu is a scholar working on Nephrology, Molecular Medicine and Immunology and Allergy, having authored 45 papers that have together received 1.6k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (10 papers), Renal Diseases and Glomerulopathies (9 papers) and Acute Kidney Injury Research (8 papers). The work is most often cited by research in Nephrology (308 citations), Biomaterials (279 citations) and Molecular Medicine (77 citations). Di Liu has collaborated with scholars based in China, United Kingdom and Czechia. Frequent co-authors include Yongzhong Du, Jing Qi, Gaofeng Shu, Feiyang Jin, Xiaoling Xu, Xiaoying Ying, Hui Yu, Jiansong Ji, Saiping Jiang and Yan Du. Their work appears in journals such as Nature Communications, Nano Letters and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.